Offering of certification mark for bioequivalence-tested drugs sought

The Korea Food and Drug Administration has recently announced it plans on the offering of certification mark for bioequivalence-tested drugs in a bid to promote the active participation of many pharmaceutical firms in the bioequivalence testing and let the people be better informed of the efficacy of bioequivalence-tested drugs.

The purpose of introducing a system to offer the certification...